Phase II clinical trial of second-line weekly paclitaxel plus trastuzumab for patients with HER2-positive metastatic gastric cancer

Anti-Cancer Drugs ◽

10.1097/cad.0000000000000691 ◽

2019 ◽

Vol 30 (1) ◽

pp. 98-104 ◽

Author(s):

Yosuke Horita ◽

Michiko Nishino ◽

Saiho Sugimoto ◽

Akihiko Kida ◽

Atsuyoshi Mizukami ◽

...

Keyword(s):

Gastric Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Metastatic Gastric Cancer ◽

Phase Ii Clinical Trial ◽

Weekly Paclitaxel ◽

Second Line ◽

Download Full-text

Phase II clinical trial of second-line weekly paclitaxel plus trastuzumab for patients with HER2-positive metastatic gastric cancer

Annals of Oncology ◽

10.1093/annonc/mdx369.071 ◽

2017 ◽

Vol 28 ◽

pp. v234

Author(s):

Y. Horita ◽

M. Nishino ◽

S. Sugimoto ◽

A. Kida ◽

A. Mizukami ◽

...

Keyword(s):

Gastric Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Metastatic Gastric Cancer ◽

Phase Ii Clinical Trial ◽

Weekly Paclitaxel ◽

Second Line ◽

Download Full-text

Phase II clinical trial of S-1 plus nanoparticle albumin-bound paclitaxel as first-line chemotherapy for patients with metastatic gastric cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.4049 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 4049-4049

Author(s):

Rui-hua Xu ◽

Ming-ming He ◽

Dong-sheng Zhang ◽

Feng Wang ◽

Ying Jin

Keyword(s):

Gastric Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Metastatic Gastric Cancer ◽

Phase Ii Clinical Trial ◽

Line Chemotherapy

Download Full-text

Abstract 6655: Tumor microenvironment evaluation and tumor intrinsic genomic features predict anti-PD-1 response of metastatic gastric cancer: Results from phase II clinical trial and multi-omics data

10.1158/1538-7445.am2020-6655 ◽

2020 ◽

Author(s):

Dongqiang Zeng ◽

Wangjun Liao ◽

Kyoung Mee Kim ◽

Min Shi ◽

Rui Zhou ◽

...

Keyword(s):

Gastric Cancer ◽

Clinical Trial ◽

Tumor Microenvironment ◽

Phase Ii ◽

Metastatic Gastric Cancer ◽

Phase Ii Clinical Trial ◽

Genomic Features

Download Full-text

Phase II clinical trial of S‐1 plus nanoparticle albumin‐bound paclitaxel in untreated patients with metastatic gastric cancer

Cancer Science ◽

10.1111/cas.13813 ◽

2018 ◽

Vol 109 (11) ◽

pp. 3575-3582 ◽

Author(s):

Ming‐ming He ◽

Feng Wang ◽

Ying Jin ◽

Shu‐qiang Yuan ◽

Chao Ren ◽

...

Keyword(s):

Gastric Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Metastatic Gastric Cancer ◽

Phase Ii Clinical Trial

Download Full-text

Phase II clinical trial of advanced and metastatic gastric cancer based on continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-008-0376-4 ◽

2008 ◽

Vol 134 (9) ◽

pp. 929-936 ◽

Author(s):

Xiaodong Zhu ◽

Jiin Leaw ◽

Weilie Gu ◽

Yiying Qian ◽

Hongyu Du ◽

...

Keyword(s):

Gastric Cancer ◽

Clinical Trial ◽

Continuous Infusion ◽

Phase Ii ◽

Metastatic Gastric Cancer ◽

Phase Ii Clinical Trial

Download Full-text

Abstract CT302: A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic or recurrent breast cancer patients with triple negative disease

10.1158/1538-7445.am2014-ct302 ◽

2014 ◽

Author(s):

Stacy Cowherd ◽

Susan Melin ◽

Steven Akman ◽

John Cole ◽

Julia Lawrence

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Cancer Patients ◽

Phase Ii ◽

Triple Negative ◽

Recurrent Breast Cancer ◽

Phase Ii Clinical Trial ◽

Weekly Paclitaxel ◽

Breast Cancer Patients ◽

Recurrent Breast

Download Full-text

A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic triple negative breast cancer

Cancer Biology & Therapy ◽

10.1080/15384047.2015.1026481 ◽

2015 ◽

Vol 16 (5) ◽

pp. 678-683 ◽

Author(s):

S Cowherd ◽

L D Miller ◽

S A Melin ◽

S Akman ◽

S Isom ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Phase Ii Clinical Trial ◽

Weekly Paclitaxel

Download Full-text

Everolimus in combination with weekly paclitaxel and trastuzumab in patients (pts) with HER2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab and taxanes: A multicenter phase II clinical trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.1013 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 1013-1013 ◽

Author(s):

F. Dalenc ◽

M. Campone ◽

P. Hupperets ◽

R. O'Regan ◽

C. Manlius ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Phase Ii Clinical Trial ◽

Weekly Paclitaxel ◽

Multicenter Phase

Download Full-text

Randomized, single-centered, phase II clinical trial of nimotuzumab plus cisplatin and S-1 as first-line therapy in patients with advanced gastric cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e21021 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e21021-e21021 ◽

Author(s):

Y. Chi ◽

Z. Zheng ◽

A. Zhou ◽

L. Yang ◽

T. Qu ◽

...

Keyword(s):

Gastric Cancer ◽

Clinical Trial ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

First Line Therapy ◽

Download Full-text

2300 A multicenter randomized phase II study of docetaxel vs. docetaxel plus cisplatin vs. docetaxel plus S-1 as second-line chemotherapy in metastatic gastric cancer patients who had progressed after cisplatin plus either S-1 or capecitabine

European Journal of Cancer ◽

10.1016/s0959-8049(16)31216-3 ◽

2015 ◽

Vol 51 ◽

pp. S432 ◽

Author(s):

B. Kim ◽

K.W. Lee ◽

M.J. Kim ◽

H.S. Han ◽

Y.L. Park ◽

...

Keyword(s):

Gastric Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Gastric Cancer ◽

Second Line ◽

Second Line Chemotherapy ◽

Randomized Phase Ii ◽

Gastric Cancer Patients ◽

Line Chemotherapy

Download Full-text